Clinical Trial Update: A Study to Determine How BI 907828 (Brigimadlin) is Taken up in the Tumor (Phase 0) and to Determine the Highest Dose of BI 907828 (Brigimadlin) That Could be Tolerated (Phase 1a) in Combination With Radiation Therapy in People With a Brain Tumor Called Glioblastoma [Phase 1]

View source ↗

Summary

The study evaluated how Brigimadlin (BI-907828) is taken up by glioblastoma tumors and identified the highest tolerated dose when given with radiation therapy i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• brigimadlin (brigimadlin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Glioblastoma | Phase 1 | Status: COMPLETED